EMBRYONIC DEVELOPMENT OF SMOOTH MUSCLE CA2+ REGULATION
EMBRYONIC DEVELOPMENT OF SMOOTH MUSCLE CA2+ REGULATION
批准号:
3446329
负责人:
MARILYN R JAMES-KRACKE
金额:
$4.09万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-01-01 至 1988-08-31
中文摘要
人们对平滑肌的发育知之甚少。
英文摘要
Little is known about the development of smooth muscle.
Excitation-contraction coupling and relaxation are still not fully
understood even in mature smooth muscles. By studying the mechanisms as
they develop new insights may emerge. A thorough understanding of the
normal development will be necessary to interpret causes of abnormal
development and pathological conditions. Much of the activity of smooth
muscle cells (contractile or metabolic) is affected by changes in the
cytoplasmic free Ca concentration ([Ca++]i). Changes in the [Ca++]i can be
indirectly monitored by changes in tension in mature muscle. In embryonic
cells, contractions are difficult or impossible to monitor. The recent
introduction of a nondisruptive method to directly measure changes in
[Ca++]i in small cells now makes this study feasible. This well-designed
method uses a permeant ester (Quin-2/AM) of a fluorescent chelator (Quin-2)
with a high affinity and selectivity for calcium (Kd=115 nM). Cellular
enzymes de-esterify Quin-2/AM thereby freeing the carboxyl groups which
bind Ca and make the molecule too hydrophilic to escape. The binding of Ca
affects the fluorescence intensity of the molecule. The development of
receptors for neurotransmitters, neuropeptides and hormones that initiate
signals for contraction or relaxation of visceral or vascular smooth
muscles and Ca transport mechanisms will be studied. This proposal focuses
on the development of cholinergic receptors in embryonic chicken gizzard
smooth muscle. This tissue is easily accessible and the best characterized
embryonic smooth muscle to date. The developmental process will be studied
in ovo and in tissue cultures. Tissue culture conditions favoring
appropriate differentiation and suitable for the Quin-2 method will be
developed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EMBRYONIC DEVELOPMENT OF SMOOTH MUSCLE CA+2 REGULATION
-
批准号:3446330
-
项目类别:
-
资助金额:$0.52万
-
财政年份:1988
-
负责人:MARILYN R JAMES-KRACKE
-
依托单位:
EMBRYONIC DEVELOPMENT OF SMOOTH MUSCLE CA2+ REGULATION
-
批准号:3446328
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1986
-
负责人:MARILYN R JAMES-KRACKE
-
依托单位:
EMBRYONIC DEVELOPMENT OF SMOOTH MUSCLE CA2+ REGULATION
-
批准号:3446327
-
项目类别:
-
资助金额:$5.3万
-
财政年份:1986
-
负责人:MARILYN R JAMES-KRACKE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
好忘方通过STIM1-Ca2+/Calmodulin-eEF2信号通路治疗阿尔茨海默病的机制研究
-
批准号:82104416
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘妍
-
依托单位:
凡纳滨对虾Ca2+/Calmodulin信号通路在低盐逆境条件下的应答调节作用研究
-
批准号:31602135
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2016
-
负责人:黄文
-
依托单位:
VEGF下调Calmodulin维持肝窦内皮细胞窗孔结构在肝纤维化中的作用及机制
-
批准号:81600485
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:程恒辉
-
依托单位:
Calmodulin的N环和C环与心肌CaV1.2钙通道的多个结合位点交互作用介导其Ca2+依赖性失活的机制研究
-
批准号:31471091
-
项目类别:面上项目
-
资助金额:86.0万元
-
批准年份:2014
-
负责人:郝丽英
-
依托单位:
Ca2+/Calmodulin通路与炎性肌损伤免疫反应的相关性研究
-
批准号:81371924
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:廖华
-
依托单位:
虎杖苷通过靶向抑制Ca2+/calmodulin激活的calcineurin-NFAT信号通路治疗心肌肥大的研究
-
批准号:81200122
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:邓建新
-
依托单位:
Ca2+/Calmodulin/NFATc1信号通路在双膦酸盐诱发破骨细胞生成抑制中作用及机制研究
-
批准号:81270965
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:戚孟春
-
依托单位:
出血性血小板病ADAM17和Calmodulin介导的血小板GPⅠb-Ⅸ-Ⅴ亚基水解活性研究及益气活血方的干预效应
-
批准号:81072945
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:沈霖
-
依托单位:
L型钙通道调节机制中calpastatin 和calmodulin的相互作用
-
批准号:30670761
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2006
-
负责人:郝丽英
-
依托单位: